Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share

Quest Diagnostics (DGX) Tops Q4 EPS by 4c, Beats on Revenue; Offers FY24 Guidance

February 1, 2024 6:49 AM EST

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $2.15, $0.04 better than the analyst estimate of $2.11. Revenue for the quarter came in at $2.29 billion versus the consensus estimate of $2.25 billion.

GUIDANCE:

Quest Diagnostics sees FY2024 EPS of $8.60-$8.90, versus the consensus of $8.99.... More